Litigation Details for ASTRAZENECA PHARMACEUTICALS LP v. FRESENIUS KABI USA, LLC (D.N.J. 2017)
✉ Email this page to a colleague
ASTRAZENECA PHARMACEUTICALS LP v. FRESENIUS KABI USA, LLC (D.N.J. 2017)
Docket | ⤷ Try a Trial | Date Filed | 2017-12-13 |
Court | District Court, D. New Jersey | Date Terminated | 2018-02-01 |
Cause | 35:271 Patent Infringement | Assigned To | Renee Marie Bumb |
Jury Demand | None | Referred To | Karen M. Williams |
Patents | 6,774,122; 7,456,160; 8,329,680; 8,466,139 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in ASTRAZENECA PHARMACEUTICALS LP v. FRESENIUS KABI USA, LLC
Details for ASTRAZENECA PHARMACEUTICALS LP v. FRESENIUS KABI USA, LLC (D.N.J. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2017-12-13 | 1 | THE PATENTS-IN-SUIT 15. United States Patent No. 6,774,122 (the “’122 Patent”), entitled…to the expiration of AstraZeneca’s U.S. Patent Nos. 6,774,122, 7,456,160, 8,329,680, and 8,466,139. … COUNT I: INFRINGEMENT OF U.S. PATENT NO. 6,774,122 32. Plaintiffs hereby reallege…OF U.S. PATENT NO. 6,774,122 43. Plaintiffs hereby reallege… This is a civil action for patent infringement under the patent laws of the United States, Title | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |